Viewing StudyNCT05817214



Ignite Creation Date: 2024-05-06 @ 6:52 PM
Last Modification Date: 2024-10-26 @ 2:56 PM
Study NCT ID: NCT05817214
Status: RECRUITING
Last Update Posted: 2024-04-19
First Post: 2023-04-05

Brief Title: Cadonilimab Plus Anlotinib for RMP Cervical Cancer
Sponsor: Zhongnan Hospital
Organization: Zhongnan Hospital

Conditions & Keywords Data

Conditions:
Name
Cervical Cancer
Keywords:
Name View
Immunotherapy View
Cervical Cancer View
Cadonilimab View
Anlotinib View
Granulocyte-macrophage colony-stimulating factor View